{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:33:39Z","timestamp":1788780819030,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Community Health and Health Behaviour"},{"name":"Mark Diamond Research Fund, The University at Buffalo, State University of New York"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.drugpo.2017.09.015","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T14:15:17Z","timestamp":1511273717000},"page":"27-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["\u2018I have it just in case\u2019 \u2014 Naloxone access and changes in opioid use behaviours"],"prefix":"10.1016","volume":"51","author":[{"given":"Sarah Cercone","family":"Heavey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ping","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie M.","family":"Vest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Lorraine","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wieczorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory G.","family":"Homish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.drugpo.2017.09.015_bib0005","doi-asserted-by":"crossref","first-page":"E153","DOI":"10.9778\/cmajo.20140008","article-title":"A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program","volume":"2","author":"Banjo","year":"2014","journal-title":"CMAJ Open"},{"key":"10.1016\/j.drugpo.2017.09.015_bib0010","series-title":"Transforming qualitative information: Thematic analysis and code development","author":"Boyatzis","year":"1998"},{"issue":"2","key":"10.1016\/j.drugpo.2017.09.015_bib0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMra1202561","article-title":"Management of opioid analgesic overdose","volume":"367","author":"Boyer","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.drugpo.2017.09.015_bib0020","series-title":"Opioid painkiller prescribing","author":"Centers for Disease Control and Prevention","year":"2014"},{"key":"10.1016\/j.drugpo.2017.09.015_bib0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jsat.2015.05.001","article-title":"Risk factors for relapse and higher costs among medicaid members with opioid dependence or abuse: Opioid agonists, comorbidities, and treatment history","volume":"57","author":"Clark","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.drugpo.2017.09.015_bib0030","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.drugalcdep.2005.10.020","article-title":"Abuse of prescription drugs and the risk of addiction","volume":"83","author":"Compton","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.09.015_bib0035","series-title":"Stata statistical software: Release 14","author":"StataCorp","year":"2015"},{"key":"10.1016\/j.drugpo.2017.09.015_bib0040","series-title":"Doing qualitative research","first-page":"163","article-title":"A template approach to text analysis: Developing and using codebooks","author":"Crabtree","year":"1999"},{"issue":"5","key":"10.1016\/j.drugpo.2017.09.015_bib0045","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.drugpo.2012.01.012","article-title":"I\u2019m not afraid of those ones just \u2018cause they\u2019ve been prescribed: Perceptions of risk among illicit users of pharmaceutical opioids","volume":"23","author":"Daniulaityte","year":"2012","journal-title":"International Journal on Drug Policy"},{"key":"10.1016\/j.drugpo.2017.09.015_bib0050","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.10.013","article-title":"Legal changes to increase access to naloxone for opioid overdose reversal in the United States","volume":"157","author":"Davis","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"9810","key":"10.1016\/j.drugpo.2017.09.015_bib0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease","volume":"379","author":"Degenhardt","year":"2012","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.drugpo.2017.09.015_bib0060","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/add.12551","article-title":"The global epidemiology and burden of opioid dependence: Results from the global burden of disease 2010 study","volume":"109","author":"Degenhardt","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.09.015_bib0065","series-title":"ATLAS.ti, version 4.2","author":"Development SS","year":"1999"},{"issue":"1","key":"10.1016\/j.drugpo.2017.09.015_bib0070","doi-asserted-by":"crossref","DOI":"10.1177\/160940690600500107","article-title":"Demonstrating rigor using thematic analysis: A hybrid approach of inductive and deductive coding and theme development","volume":"5","author":"Fereday","year":"2006","journal-title":"International Journal of Qualitative Methods"},{"issue":"7","key":"10.1016\/j.drugpo.2017.09.015_bib0075","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3109\/10826084.2013.787099","article-title":"Barriers to medical provider support for prescription naloxone as overdose antidote for lay responders","volume":"48","author":"Green","year":"2013","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.drugpo.2017.09.015_bib0080","series-title":"Buffalo drug dealer charged in opioid overdose","author":"Gyryta","year":"2016"},{"issue":"2","key":"10.1016\/j.drugpo.2017.09.015_bib0085","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"Journal of Biomedical Informatics"},{"issue":"3","key":"10.1016\/j.drugpo.2017.09.015_bib0090","first-page":"235","article-title":"Reducing fatal opioid overdose: Prevention, treatment and harm reduction strategies","volume":"88","author":"Hawk","year":"2015","journal-title":"Yale Journal of Biology and Medicine"},{"key":"10.1016\/j.drugpo.2017.09.015_bib0095","article-title":"Overdose education and naloxone distribution program attendees: Who attends, what do they know, and how do they feel?","author":"Heavey","year":"2017","journal-title":"Journal of Public Health Management and Practice"},{"issue":"1\u20132","key":"10.1016\/j.drugpo.2017.09.015_bib0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2013.01.007","article-title":"Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers: United States, 2002\u20132004 and 2008\u20132010","volume":"132","author":"Jones","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"0","key":"10.1016\/j.drugpo.2017.09.015_bib0105","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annual Review of Public Health"},{"key":"10.1016\/j.drugpo.2017.09.015_bib0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugalcdep.2003.09.005","article-title":"Social network correlates of self-reported non-fatal overdose","volume":"73","author":"Latkin","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.drugpo.2017.09.015_bib0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugpo.2013.10.004","article-title":"Every \u2018never\u2019 i ever said came true: Transitions from opioid pills to heroin injecting","volume":"25","author":"Mars","year":"2014","journal-title":"International Journal on Drug Policy"},{"key":"10.1016\/j.drugpo.2017.09.015_bib0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.drugpo.2016.11.015","article-title":"Experiences of peer-trainers in a take-home naloxone program: Results from a qualitative study","volume":"41","author":"Marshall","year":"2017","journal-title":"International Journal on Drug Policy"},{"issue":"11","key":"10.1016\/j.drugpo.2017.09.015_bib0125","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.2105\/AJPH.2015.302843","article-title":"Worldwide prevalence and trends in unintentional drug overdose: A systematic review of the literature","volume":"105","author":"Martins","year":"2015","journal-title":"American Journal of Public Health"},{"issue":"8","key":"10.1016\/j.drugpo.2017.09.015_bib0130","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2105\/AJPH.2016.303297","article-title":"The Ongoing Opioid Prescription Epidemic: Historical Context","volume":"106","author":"Meldrum","year":"2016","journal-title":"American Journal Public Health"},{"issue":"2","key":"10.1016\/j.drugpo.2017.09.015_bib0135","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1037\/a0034127","article-title":"Ecological momentary assessment of the effects of craving and affect on risk for relapse during substance abuse treatment","volume":"28","author":"Moore","year":"2014","journal-title":"Addictive Behaviors"},{"issue":"2","key":"10.1016\/j.drugpo.2017.09.015_bib0140","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/08897077.2015.1010032","article-title":"A review of opioid overdose prevention and naloxone prescribing: Implications for translating community programming into clinical practice","volume":"36","author":"Mueller","year":"2015","journal-title":"Substance Abuse"},{"issue":"4","key":"10.1016\/j.drugpo.2017.09.015_bib0145","first-page":"493","article-title":"Transitions to injecting drug use among noninjecting heroin users \u2014 Social network influence and individual susceptibility","volume":"41","author":"Neaigus","year":"2006","journal-title":"JAIDS: Journal of Acquired Immune Deficiency Syndromes"},{"issue":"3","key":"10.1016\/j.drugpo.2017.09.015_bib0150","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0092-6566(03)00067-9","article-title":"A review of behavioral and biological correlates of sensation seeking","volume":"38","author":"Roberti","year":"2004","journal-title":"Journal of Research in Personality"},{"issue":"50 & 51","key":"10.1016\/j.drugpo.2017.09.015_bib0155","article-title":"Increases in drug and opioid-involved overdose deaths \u2014 United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR: Morbidity and Mortality Weekly Report"},{"issue":"13","key":"10.1016\/j.drugpo.2017.09.015_bib0160","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1080\/10826084.2016.1197267","article-title":"Public perspectives on expanding naloxone access to reverse opioid overdoses","volume":"51","author":"Rudski","year":"2016","journal-title":"Substance Use and Misuse"},{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2017.09.015_bib0165","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.jsat.2004.09.006","article-title":"Pathways in the relapse\u2013treatment\u2013recovery cycle over 3 years","volume":"28","author":"Scott","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.drugpo.2017.09.015_bib0170","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of oxycontin: commercial triumph, public health tragedy","volume":"99","author":"Van Zee","year":"2009","journal-title":"American Journal Public Health"},{"issue":"3","key":"10.1016\/j.drugpo.2017.09.015_bib0175","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.drugpo.2009.01.003","article-title":"Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA","volume":"21","author":"Wagner","year":"2010","journal-title":"International Journal on Drug Policy"},{"issue":"1","key":"10.1016\/j.drugpo.2017.09.015_bib0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.drugpo.2013.07.003","article-title":"I felt like a superhero: The experience of responding to drug overdose among individuals trained in overdose prevention","volume":"25","author":"Wagner","year":"2014","journal-title":"International Journal on Drug Policy"},{"key":"10.1016\/j.drugpo.2017.09.015_bib0185","series-title":"Community management of opioid overdose","article-title":"WHO guidelines approved by the guidelines review committee","author":"World Health Organization","year":"2014"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917302931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917302931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T01:18:38Z","timestamp":1583889518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395917302931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":37,"alternative-id":["S0955395917302931"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.09.015","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u2018I have it just in case\u2019 \u2014 Naloxone access and changes in opioid use behaviours","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}